NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/30/2025
Back to search
Official data from USPTO
SUNSHINE BIOPHARMA INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
10/14/2025
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
06/06/2022
Registration date
09/30/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/30/2025
Last transaction
10/14/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
First use anywhere
2019-02-00
First use in commerce
2019-02-00
Drawing code
3
Owner type
99
Owner location
Pointe-Claire, QC, CA
Examiner
SHIH,SALLY
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the terms "SUNSHINE BIOPHARMA INC." in blue lettering to the right of an image of a stylized representation of a partial double helix comprised of a left helix of a darker blue and a right helix of a lighter blue. Between the two helixes, are yellow stripes from varying widths commencing with a thin line at the bottom and ending with a thicker band at the top, against a white background.
Holders and representatives
Holders
Sunshine Biopharma Inc.
Representatives
W. Drew Kastner Offit Kurman, P.A.
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Dietary supplements consisting of amino acidsminerals and trace elements; pharmaceutical preparations for the prevention and treatment of cancer; pharmaceuticals for the treatment or prevention of coronavirus diseasesrespiratory diseases and covid-19
Class 35
New product commercialization services in the field of nutritional supplements
Class 42
Pharmaceutical drug development services; pharmaceutical research and development services; development of nutritional supplements; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the field of coronavirus diseasesrespiratory diseases and covid-19
Publications
History of USPTO decisions and trademark events.
46 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
09/30/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/18/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/18/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/18/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/12/2025
PUBO
PUBLISHED FOR OPPOSITION
08/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/06/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/02/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/30/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/30/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
06/30/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
04/01/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
04/01/2025
CNSI
SUSPENSION INQUIRY WRITTEN
04/01/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
03/27/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/03/2024
GNSL
LETTER OF SUSPENSION E-MAILED
09/03/2024
CNSL
SUSPENSION LETTER WRITTEN
09/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/27/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/27/2024
ALIE
ASSIGNED TO LIE
08/27/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/20/2024
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/10/2024
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/10/2024
CNSI
SUSPENSION INQUIRY WRITTEN
01/10/2024
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
01/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/05/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/05/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/05/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/05/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/05/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/05/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/15/2023
GNSL
LETTER OF SUSPENSION E-MAILED
05/15/2023
CNSL
SUSPENSION LETTER WRITTEN
05/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/21/2023
GNRT
NON-FINAL ACTION E-MAILED
03/21/2023
CNRT
NON-FINAL ACTION WRITTEN
03/21/2023
DOCK
ASSIGNED TO EXAMINER
03/21/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/16/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/15/2022
NWAP
NEW APPLICATION ENTERED
06/09/2022
Continuous trademark protection
Get notified about every new filing that threatens SUNSHINE BIOPHARMA INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.